ADT Biotech’s latest product, the LyteStar™ COVID / Flu / RSV Differentiation Kit has achieved regulatory approval by the Malaysian Medical Device Authority (MDA).
The LyteStar™ COVID / Flu / RSV Differentiation RT-PCR Kit is a four-target assay intended for the specific detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) RNA in human respiratory specimens, comprising of detection and differentiation assays targeting the SARS-CoV-2 specific RNA-dependent RNA polymerase (RdRP) gene, the Influenza A specific Matrix (M) gene, the Influenza B specific Haemagglutinin (HA) gene and the RSV specific Matrix (M) gene.